Amprion Announces Presentation of Findings Related to Usage of the αSynuclein Seed Amplification Assay in Recent Parkinson's Study at 2023 AAN Annual Meeting
SAN DIEGO, April 21, 2023 /PRNewswire/ -- Amprion is pleased to announce that it will attend the American Academy of Neurology (AAN) Annual Meeting in Boston April 22-27 to share insights about its SYNTap Biomarker Test, a first-in-class qualitative Laboratory Developed Test (LDT) and the only seed amplification assay available to aid physicians in diagnosing synucleinopathies.
- To learn more about SYNTap during the meeting, attendees can visit the Exhibit Hall to:
Meet with the Amprion team in Booth 668. - Attend Dr. Andrew Siderowf's presentation at 2 p.m. EST on Monday, April 24 on the Emerging Neurologic Care Presentation Stage.
- The talk is titled "High Diagnostic Accuracy of Amprion's SAA Assay Informs PD Heterogeneity and Disease Onset in Analysis of the PPMI Cohort."
- In his presentation, Dr. Siderowf will discuss how Amprion's αSyn Seed Amplification Assay was utilized in the landmark PPMI paper, which was published in The Lancet Neurology journal on April 12, 2023.